Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

Dose-escalation study was performed to evaluate the maximum tolerated dose, recommended dose and toxicity profile of weekly irinotecan with daily carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer. Thirty-one previously untreated patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, M, Kudoh, S, Fukuda, H, Nakagawa, K, Yamamoto, N, Nishimura, Y, Negoro, S, Takeda, K, Tanaka, M, Fukuoka, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364228/
https://www.ncbi.nlm.nih.gov/pubmed/12177791
http://dx.doi.org/10.1038/sj.bjc.6600464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364228/
https://www.ncbi.nlm.nih.gov/pubmed/12177791
http://dx.doi.org/10.1038/sj.bjc.6600464

Ejemplares similares